For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260529:nRSc3215Ga&default-theme=true
RNS Number : 3215G GenIP PLC 29 May 2026
29 May 2026
GenIP Plc
("GenIP" or the "Company")
Total Voting Rights
In conformity with the Disclosure Guidance and Transparency Rules ("DTRs") of
the Financial Conduct Authority (the "FCA"), GenIP Plc (AIM:GNIP), a
technology consultancy providing AI-driven services to help research
organisations and corporations commercialise their innovations, announces that
as at the date of this announcement the Company's total issued share capital
consists of 25,517,461 ordinary shares of £0.00425 with voting rights
("Ordinary Shares"). The Company does not hold any Ordinary Shares in
treasury and accordingly there are no voting rights in respect of any treasury
shares.
The abovementioned figure of 25,517,461 Ordinary Shares may be used by
shareholders in the Company as the denominator for the calculations by which
they will determine if they are required to notify their interest in, or a
change to their interest in, GenIP under the FCA's DTRs.
ENDS
For further information regarding GenIP, please visit www.genip.ai
(http://www.genip.ai/) , or contact:
GenIP Plc Via Redchurch Communications
Melissa Cruz, CEO
Beaumont Cornish Limited (Nominated Adviser) Tel: +44 (0) 20 7628 3396
Roland Cornish / Asia Szusciak
AlbR Capital Limited (Broker) Tel: +44 (0) 20 7399 9427
Colin Rowbury cr@albrcapital.com (mailto:cr@albrcapital.com)
Jon Belliss Jb@albrcapital.com (mailto:Jb@albrcapital.com)
CMC Markets (Joint Broker) Tel: +44 (0) 20 3003 8632
Douglas Crippen
Redchurch Communications (Financial PR) genip@weareredchurch.com (mailto:genip@weareredchurch.com)
John Casey
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TVRPPURCAUPQGQB
Copyright 2019 Regulatory News Service, all rights reserved